Nearly half of patients with advanced ovarian cancer treated with first-line poly-ADP-ribose polymerase (PARP) inhibitors experienced recurrence in this real-world study, emphasizing the need for ...

Ovarian cancer has seen a significant shift in its treatment paradigm with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, which are now standard in the maintenance setting ...

Thanks to the scientists at the University of Oxford, this disease could be eradicated in the next few decades.

Researchers at Peter Mac have uncovered potential new heredity genes that might be responsible for causing one of the most prevalent and deadliest forms of ovarian cancer. Their work is published in ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects ...

The "Ovarian Cancer Market by Type, by Diagnosis Scans, by Treatment, by End-user, and by Region" report has been added to ...

Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm with the introduction ...

The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...

Jemma Bruce, 22, from Irvine in North Ayrshire, was first diagnosed with a benign ovarian tumour at 13, before another tumour ...

One reason is the fact that much research related to ovarian cancer has focused on strategies combining chemotherapy with ...